Select a CDMO using product fit, quality responsibilities, commercial clarity, and evidence of a workable handoff.
The source context
FDA publishes current good manufacturing practice resources for food and dietary supplements. Applicable quality requirements are foundational; they do not replace a product-specific assessment of manufacturing fit. Source ↗
PCG perspective · The following is our proposed development framework, not a finding of the cited source.
Start with the process your product needs
Give prospective partners a consistent brief covering format, target specification, expected volume, packaging, testing, and launch constraints. Ask what parts of the process they perform directly and what they outsource. A partner may be strong in one format and less suited to another. Compare relevant capabilities rather than the overall size or visual sophistication of the facility.
Make the handoff explicit
Identify who owns the master specification, who approves changes, and who signs off on production readiness. Clarify which development assumptions still need to be confirmed at scale. A successful prototype does not remove the need for a controlled handoff. The practical question is whether both teams understand what must stay consistent and how exceptions will be handled.
Compare the commercial structure
Review minimum quantities, lead times, development charges, testing, packaging responsibilities, and payment terms. Ask how changes in raw material costs or forecasts affect the agreement. Where a development partner is compensated by the manufacturer, disclose that structure and understand how it interacts with the client’s objectives. Transparency makes it easier to evaluate recommendations on their merits.
Test the working relationship
Before a major commitment, use a structured technical meeting or pilot milestone to assess responsiveness and problem solving. Does the team document decisions? Can it explain a limitation clearly? Are open items assigned and resolved? These behaviors are difficult to infer from a tour but become important when the project encounters its first unexpected constraint.
Source & scope
FDA: Current Good Manufacturing Practices ↗US regulatory resource; checked September 21, 2026. Sources checked September 21, 2026. Product-specific scientific and regulatory conclusions require appropriate specialist review.
How we prepare and update insightsTurn the question into a development brief.
Explore formulation, sourcing, research, or portfolio decisions with Product Concept Group.
Discuss this opportunity ↗